Beijing New Oriental Star Petrochemical Engineering Co Ltd (002755) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.057x

Based on the latest financial reports, Beijing New Oriental Star Petrochemical Engineering Co Ltd (002755) has a cash flow conversion efficiency ratio of 0.057x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥187.71 Million ≈ $27.47 Million USD) by net assets (CN¥3.27 Billion ≈ $478.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Beijing New Oriental Star Petrochemical Engineering Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Beijing New Oriental Star Petrochemical Engineering Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Beijing New Oriental Star Petrochemical (002755) financial obligations for a breakdown of total debt and financial obligations.

Beijing New Oriental Star Petrochemical Engineering Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Beijing New Oriental Star Petrochemical Engineering Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Shenzhen Kangtai Biological Products Co Ltd
SHE:300601
0.042x
Transportadora de Gas del Sur SA B
BA:TGSU2
0.045x
Asahi India Glass Limited
NSE:ASAHIINDIA
0.038x
DRDGOLD Limited
F:DUBA
0.066x
OLAM GROUP LTD
F:K25
N/A
Bavarian Nordic
CO:BAVA
0.098x
SOC.BIC UNS.ADR1/2/EO382
F:BIF0
N/A
Yunnan Shennong Agricultural Industry Group Co Ltd
SHG:605296
-0.018x

Annual Cash Flow Conversion Efficiency for Beijing New Oriental Star Petrochemical Engineering Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Beijing New Oriental Star Petrochemical Engineering Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see 002755 stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥3.14 Billion
≈ $459.81 Million
CN¥411.36 Million
≈ $60.19 Million
0.131x +1583.47%
2023-12-31 CN¥3.01 Billion
≈ $440.56 Million
CN¥-26.57 Million
≈ $-3.89 Million
-0.009x +49.65%
2022-12-31 CN¥3.01 Billion
≈ $440.95 Million
CN¥-52.81 Million
≈ $-7.73 Million
-0.018x -109.96%
2021-12-31 CN¥3.23 Billion
≈ $472.29 Million
CN¥567.71 Million
≈ $83.07 Million
0.176x -8.07%
2020-12-31 CN¥3.03 Billion
≈ $443.85 Million
CN¥580.38 Million
≈ $84.93 Million
0.191x -9.93%
2019-12-31 CN¥2.52 Billion
≈ $368.25 Million
CN¥534.62 Million
≈ $78.23 Million
0.212x -21.33%
2018-12-31 CN¥1.84 Billion
≈ $269.39 Million
CN¥497.16 Million
≈ $72.75 Million
0.270x +414.08%
2017-12-31 CN¥585.03 Million
≈ $85.61 Million
CN¥-50.30 Million
≈ $-7.36 Million
-0.086x -361.81%
2016-12-31 CN¥509.40 Million
≈ $74.54 Million
CN¥16.73 Million
≈ $2.45 Million
0.033x +2179.89%
2015-12-31 CN¥508.35 Million
≈ $74.39 Million
CN¥-802.68K
≈ $-117.46K
-0.002x +98.51%
2014-12-31 CN¥333.61 Million
≈ $48.82 Million
CN¥-35.30 Million
≈ $-5.17 Million
-0.106x -143.79%
2013-12-31 CN¥307.51 Million
≈ $45.00 Million
CN¥-13.35 Million
≈ $-1.95 Million
-0.043x -110.74%
2012-12-31 CN¥263.39 Million
≈ $38.54 Million
CN¥106.47 Million
≈ $15.58 Million
0.404x +160.84%
2011-12-31 CN¥214.83 Million
≈ $31.44 Million
CN¥33.29 Million
≈ $4.87 Million
0.155x --

About Beijing New Oriental Star Petrochemical Engineering Co Ltd

SHE:002755 China Drug Manufacturers - Specialty & Generic
Market Cap
$2.30 Billion
CN¥15.73 Billion CNY
Market Cap Rank
#5754 Global
#1202 in China
Share Price
CN¥16.95
Change (1 day)
+4.57%
52-Week Range
CN¥13.48 - CN¥28.40
All Time High
CN¥38.01
About

Beijing Aosaikang Pharmaceutical Co., Ltd. researches, develops, manufactures, markets, and sells pharmaceuticals, fine chemicals, and health-care products in China. It offers proton pump inhibitor injections and oncology medicines, as well as APIs. The company provides its products in oncology, antibiotic, and other areas. Beijing Aosaikang Pharmaceutical Co., Ltd. was founded in 2003 and is bas… Read more